Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem Cells
Nabanita Mukherjee, Josianna V. Schwan, Mayumi Fujita, et al.
Journal of Investigative Dermatology (2015) Vol. 135, Iss. 9, pp. 2155-2161
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer
Simona D’Aguanno, Donatella Del Bufalo
Cells (2020) Vol. 9, Iss. 5, pp. 1287-1287
Open Access | Times Cited: 122
Current State of Animal (Mouse) Modeling in Melanoma Research
Omer F. Kuzu, Felix Nguyen, Mohammad A. Noory, et al.
Cancer Growth and Metastasis (2015) Vol. 8s1, pp. CGM.S21214-CGM.S21214
Open Access | Times Cited: 94
Advances in the Understanding of Skin Cancer: Ultraviolet Radiation, Mutations, and Antisense Oligonucleotides as Anticancer Drugs
Kateryna V. Laikova, Volodymyr V. Oberemok, Alisa M. Krasnodubets, et al.
Molecules (2019) Vol. 24, Iss. 8, pp. 1516-1516
Open Access | Times Cited: 94
BCL-XL overexpression promotes tumor progression-associated properties
Daniela Trisciuoglio, Maria Grazia Tupone, Marianna Desideri, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 12
Open Access | Times Cited: 92
Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma
Dhiraj Kumar, Mahadeo Gorain, Gautam Kundu, et al.
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 69
pH- and GSH-Sensitive Hyaluronic Acid-MP Conjugate Micelles for Intracellular Delivery of Doxorubicin to Colon Cancer Cells and Cancer Stem Cells
Tilahun Ayane Debele, Lu-Yi Yu, Cheng-Sheng Yang, et al.
Biomacromolecules (2018) Vol. 19, Iss. 9, pp. 3725-3737
Closed Access | Times Cited: 59
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
Nabanita Mukherjee, Jenette Skees, Kaleb J. Todd, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 6
Open Access | Times Cited: 59
Drug and apoptosis resistance in cancer stem cells (CSCs): A puzzle with many pieces
Ahmad R. Safa
Cancer Drug Resistance (2022) Vol. 5, Iss. 4, pp. 850-72
Open Access | Times Cited: 32
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
Nabanita Mukherjee, Elizabeth Katsnelson, Tonya M. Brunetti, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 5
The role of mitophagy-related genes in prognosis and immunotherapy of cutaneous melanoma: a comprehensive analysis based on single-cell RNA sequencing and machine learning
Jun Tian, Lei Zhang, Kexin Shi, et al.
Immunologic Research (2025) Vol. 73, Iss. 1
Closed Access
Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages
Marta Di Martile, Valentina Farini, Francesca Maria Consonni, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000489-e000489
Open Access | Times Cited: 37
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
Jie Yin, Gangyin Zhao, Helen Kalirai, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 598-598
Open Access | Times Cited: 11
Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival
Silvia Pietrobono, Andrea Morandi, Sinforosa Gagliardi, et al.
Journal of Investigative Dermatology (2016) Vol. 136, Iss. 10, pp. 2059-2069
Open Access | Times Cited: 34
A novel double-targeted nondrug delivery system for targeting cancer stem cells
Shupei Qiao, Yufang Zhao, Shuai Geng, et al.
International Journal of Nanomedicine (2016) Vol. Volume 11, pp. 6667-6678
Open Access | Times Cited: 34
Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells
Nabanita Mukherjee, Yan Lü, Adam R. Almeida, et al.
Oncotarget (2016) Vol. 8, Iss. 29, pp. 46801-46817
Open Access | Times Cited: 31
Resistance to drugs and cell death in cancer stem cells (CSCs)
Ahmad R. Safa
Journal of Translational Science (2020) Vol. 6, Iss. 3
Open Access | Times Cited: 26
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma
Nabanita Mukherjee, Carol M. Amato, Jenette Skees, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2182-2182
Open Access | Times Cited: 25
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
Nabanita Mukherjee, Andrew Strosnider, Bay Vagher, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 9
Open Access | Times Cited: 26
Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments
Nabanita Mukherjee, Adam R. Almeida, Katie Partyka, et al.
Oncotarget (2016) Vol. 7, Iss. 51, pp. 84594-84607
Open Access | Times Cited: 25
Vanillic Acid Improves Comorbidity of Cancer and Obesity through STAT3 Regulation in High-Fat-Diet-Induced Obese and B16BL6 Melanoma-Injected Mice
Jinbong Park, Seon Yeon Cho, JongWook Kang, et al.
Biomolecules (2020) Vol. 10, Iss. 8, pp. 1098-1098
Open Access | Times Cited: 23
Overcoming Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutated Tumours
Emily L. Paton, Jacqueline A. Turner, Isabel R. Schlaepfer
Journal of Oncology (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 20
BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance
María Josefina Quezada, María Elisa Picco, María Belén Villanueva, et al.
Cancers (2020) Vol. 13, Iss. 1, pp. 78-78
Open Access | Times Cited: 20
Patient-derived tumor xenograft models for melanoma drug discovery
Antoneicka L. Harris, Richard W. Joseph, John A. Copland
Expert Opinion on Drug Discovery (2016) Vol. 11, Iss. 9, pp. 895-906
Closed Access | Times Cited: 18
Current trends in the treatment of malignant melanoma
Marcela Valko-Rokytovská, K. BRUCHATA, Jana Šimková, et al.
Neoplasma (2016) Vol. 63, Iss. 03, pp. 333-341
Open Access | Times Cited: 15
Network analysis of mitonuclear GWAS reveals functional networks and tissue expression profiles of disease-associated genes
Simon C. Johnson, Brenda González, Quanwei Zhang, et al.
Human Genetics (2016) Vol. 136, Iss. 1, pp. 55-65
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top